| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director | Director, 10% Owner
16 companies
Sonsini Peter W. serves as a 10% Owner at NEUE and has filed Form 4s across 16 companies. Across recent SEC filings that breaks down to 26 buys and 4 sells. Those positions are worth an estimated $305.5M at current prices.
Historically, Sonsini Peter W.'s trades have earned a below-average insider score of 42/100 across 4 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -24.4%.
The biggest single holding is GLUE (~$146.2M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 1,050,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2022 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Buy | 3,580,526 | $1.90 | $6,802,999.40 | -136.1% | +31.2% | -32.7% | |
| Oct 18, 2021 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Buy | 1,851,852 | $0.00 | - | +31.2% | -40.8% | +62.7% | |
| Jun 28, 2021 | NEUE Neuehealth, Inc. | 10% Owner | Buy | 1,944,444 | $18.00 | $34,999,992.00 | +8.8% | - | - | |
| Jun 28, 2021 | GLUE Monte Rosa Therapeutics, Inc. | 10% Owner | Buy | 1,050,000 | $19.00 | $19,950,000.00 | +15.8% | +28.8% | -49.9% | |
| Mar 16, 2021 | MRKR Marker Therapeutics, Inc. | 10% Owner | Buy | 5,714,285 | $1.75 | $9,999,998.75 | +114.3% | +91.4% | -77.7% | |
| Jul 14, 2020 | NKTX Nkarta, Inc. | 10% Owner | Buy | 666,666 | $18.00 | $11,999,988.00 | +29.8% | - | - | |
| Apr 3, 2020 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Sell | 564 | $2.66 | $1,500.24 | - | - | - | |
| Jan 24, 2020 | 10% Owner | Buy | 7,500,000 | $0.67 | $5,000,250.00 | +62.5% | - | - | ||
| Jul 22, 2019 | MIRM Mirum Pharmaceuticals, Inc. | 10% Owner | Buy | 450,000 | $15.00 | $6,750,000.00 | +12.0% | - | - | |
| May 9, 2019 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Buy | 2,500,000 | $10.00 | $25,000,000.00 | +129.0% | - | - |